Related Experiment Videos
Transgenic models for the study of endothelin function in the cardiovascular system
1Institute of Clinical Pharmacology and Toxicology, Free University Berlin, Germany.
Journal of Cardiovascular Pharmacology
|September 8, 2000
Summary
Understanding cardiovascular disease requires studying the endothelin system. This review covers transgenic models used to investigate endothelin
Area of Science:
- Cardiovascular Physiology and Pathophysiology
- Endothelin System Biology
- Transgenic Model Development
Background:
- Cardiovascular diseases (CVDs) are a leading cause of mortality globally.
- Understanding CVD pathogenesis is crucial for developing effective treatments.
- The endothelin system is implicated in the development of cardiovascular diseases.
Purpose of the Study:
- To review existing transgenic models of the endothelin system.
- To highlight recent advancements in transgenic endothelin research.
- To provide insights into dissecting pathophysiological factors in CVDs.
Main Methods:
- Investigation of classical pharmacological and molecular biological approaches.
- Utilizing specific animal models for cardiovascular research.
- Development and application of novel transgenic methods for gene function studies.
Main Results:
- Several transgenic models with gain or loss of function strategies have been established for endothelin system components.
- These models facilitate the dissection of pathophysiological factors influencing CVD development.
- Evidence supports a significant role for the endothelin system in CVD pathogenesis.
Conclusions:
- Transgenic models are valuable tools for studying the endothelin system in cardiovascular disease.
- Further research using these models can deepen our understanding of CVD.
- Advancements in transgenic technology are crucial for future cardiovascular research.